Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Bourin

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Arthritis and Rheumatism|April 25, 2013
Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2Cristina Manferdini, Marie Maumus, Elena Gabusi, et al.
Acta Biomaterialia|November 12, 2013
Evaluation of polyelectrolyte complex-based scaffolds for mesenchymal stem cell therapy in cardiac ischemia treatmentCaroline Ceccaldi, Raya Bushkalova, Chiara Alfarano, et al.
Arthritis and Rheumatism|April 5, 2013
Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID miceKarine Toupet, Marie Maumus, Julie-Anne Peyrafitte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in miceMuriel Sudres, Françoise Norol, Aurélie Trenado, et al.
Stem Cells and Development|January 24, 2013
Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controlsCedric Menard, Luciano Pacelli, Giulio Bassi, et al.
Cytotherapy|February 3, 2012
Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active componentsNatalie Fekete, Mélanie Gadelorge, Daniel Fürst, et al.
Oncotarget|September 13, 2015
IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine productionPauline Escobar, Céline Bouclier, Julien Serret, et al.
Stem Cells (Dayton, Ohio)|May 10, 2008
Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidneyCéline Mias, Elodie Trouche, Marie-Hélène Seguelas, et al.
Stem Cells (Dayton, Ohio)|July 11, 2009
Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarctionCéline Mias, Olivier Lairez, Elodie Trouche, et al.
Cancer Research|February 4, 2012
Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myelomaJill Corre, Elodie Labat, Nicolas Espagnolle, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Arthritis and Rheumatism|April 25, 2013
Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2Cristina Manferdini, Marie Maumus, Elena Gabusi, et al.
Acta Biomaterialia|November 12, 2013
Evaluation of polyelectrolyte complex-based scaffolds for mesenchymal stem cell therapy in cardiac ischemia treatmentCaroline Ceccaldi, Raya Bushkalova, Chiara Alfarano, et al.
Arthritis and Rheumatism|April 5, 2013
Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID miceKarine Toupet, Marie Maumus, Julie-Anne Peyrafitte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in miceMuriel Sudres, Françoise Norol, Aurélie Trenado, et al.
Stem Cells and Development|January 24, 2013
Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controlsCedric Menard, Luciano Pacelli, Giulio Bassi, et al.
Cytotherapy|February 3, 2012
Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active componentsNatalie Fekete, Mélanie Gadelorge, Daniel Fürst, et al.
Oncotarget|September 13, 2015
IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine productionPauline Escobar, Céline Bouclier, Julien Serret, et al.
Stem Cells (Dayton, Ohio)|May 10, 2008
Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidneyCéline Mias, Elodie Trouche, Marie-Hélène Seguelas, et al.
Stem Cells (Dayton, Ohio)|July 11, 2009
Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarctionCéline Mias, Olivier Lairez, Elodie Trouche, et al.
Cancer Research|February 4, 2012
Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myelomaJill Corre, Elodie Labat, Nicolas Espagnolle, et al.
Pageof 6